Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT

Reassurance for Patients Regarding NECC-Produced Products

Media Inquiries

news@uwhealth.org

 

Patient Relations

(608) 263-8009

 

Follow Us

Twitter icon Follow UW Health on Twitter

Twitter icon Follow UW Health on Facebook

Madison, Wisconsin - UW Health wishes to reassure all of our patients, faculty and staff that we have never purchased the products from the New England Compounding Center (NECC) that have been associated with transmission of fungal infection.

 

Thus, no UW Health patient has ever received these products while in our care. Additionally, UW Health has removed all NECC-produced products from our pharmacies.

 

The Food and Drug Administration (FDA) initially notified the public and healthcare organizations that methylprednisolone, a steroid injection used in the treatment of low back pain, was contaminated with a fungus.

 

On October 15th, the FDA released a statement warning that two more products from NECC have been associated with transmission of fungal infection. The two medications are triamcinolone acetonide for injection and cardioplegia solution used during cardiac surgery to protect the heart. We continue to monitor the status of the investigation into drugs associated with fungal infection that were distributed by NECC, and will continue to provide updated information on this site.

 

Patients or family members who have questions may contact our Patient Relations Department at (608) 263-8009.


Date Published: 10/18/2012


News RSS Feed